Publicaciones en colaboración con investigadores/as de Monash University (14)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights

    European Urology, Vol. 84, Núm. 1, pp. 127-137

  3. Sudden-Onset Disaster Mass-Casualty Incident Response: A Modified Delphi Study on Triage, Prehospital Life Support, and Processes

    Prehospital and Disaster Medicine, Vol. 38, Núm. 5, pp. 570-580

2022

  1. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2021

  1. Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: Results from the phase III, placebo-controlled QUAZAR AML-001 trial

    Haematologica

  2. Osteoporosis management in hematologic stem cell transplant recipients: Executive summary

    Journal of Bone Oncology, Vol. 28

2020

  1. Body mass index and weight change are associated with adult lung function trajectories: The prospective ECRHS study

    Thorax, Vol. 75, Núm. 4, pp. 313-320

2019

  1. Occupational exposures and incidence of chronic bronchitis and related symptoms over two decades: The European Community Respiratory Health Survey

    Occupational and Environmental Medicine, Vol. 76, Núm. 4, pp. 222-229

  2. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)

    Nature Communications

  3. Shared heritability and functional enrichment across six solid cancers

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Bone management in hematologic stem cell transplant recipients

    Osteoporosis International, Vol. 29, Núm. 12, pp. 2597-2610

  2. Prevalence of asthma-like symptoms with ageing

    Thorax, Vol. 73, Núm. 1, pp. 37-48

2015

  1. IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma

    British Journal of Cancer, Vol. 112, Núm. 7, pp. 1190-1198

2014

  1. Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial

    The Lancet Oncology, Vol. 15, Núm. 3, pp. 286-296